4/18
08:30 am
cers
Cerus Corporation to Release First Quarter 2024 Financial Results on May 2, 2024
Low
Report
Cerus Corporation to Release First Quarter 2024 Financial Results on May 2, 2024
4/18
07:10 am
cers
Cerus Corporation (NASDAQ:CERS) is a favorite amongst institutional investors who own 64% [Yahoo! Finance]
Neutral
Report
Cerus Corporation (NASDAQ:CERS) is a favorite amongst institutional investors who own 64% [Yahoo! Finance]
4/12
01:01 pm
cers
Cerus gains as Craig Hallum launches at Buy on return to growth [Seeking Alpha]
Low
Report
Cerus gains as Craig Hallum launches at Buy on return to growth [Seeking Alpha]
4/12
08:05 am
cers
Cerus Co. (NASDAQ: CERS) is now covered by analysts at Craig Hallum. They set a "buy" rating and a $5.00 price target on the stock.
Medium
Report
Cerus Co. (NASDAQ: CERS) is now covered by analysts at Craig Hallum. They set a "buy" rating and a $5.00 price target on the stock.
3/26
08:42 am
cers
Cerus Corporation Announces FDA Approval of Extended Shelf Life for INTERCEPT Platelet Processing Sets – Doubling Previous Shelf Life [Yahoo! Finance]
Medium
Report
Cerus Corporation Announces FDA Approval of Extended Shelf Life for INTERCEPT Platelet Processing Sets – Doubling Previous Shelf Life [Yahoo! Finance]
3/26
08:30 am
cers
Cerus Corporation Announces FDA Approval of Extended Shelf Life for INTERCEPT Platelet Processing Sets – Doubling Previous Shelf Life
Medium
Report
Cerus Corporation Announces FDA Approval of Extended Shelf Life for INTERCEPT Platelet Processing Sets – Doubling Previous Shelf Life
3/19
08:54 am
cers
Cerus' soars on meeting main goal of late stage trial for INTERCEPT RBCs in heart surgery patients [Seeking Alpha]
High
Report
Cerus' soars on meeting main goal of late stage trial for INTERCEPT RBCs in heart surgery patients [Seeking Alpha]
3/19
08:13 am
cers
Cerus Corporation Announces Positive Topline Results for the Phase 3 Clinical Trial of the INTERCEPT Blood System for Red Blood Cells in Cardiovascular Surgery Patients [Yahoo! Finance]
Medium
Report
Cerus Corporation Announces Positive Topline Results for the Phase 3 Clinical Trial of the INTERCEPT Blood System for Red Blood Cells in Cardiovascular Surgery Patients [Yahoo! Finance]
3/19
08:00 am
cers
Cerus Corporation Announces Positive Topline Results for the Phase 3 Clinical Trial of the INTERCEPT Blood System for Red Blood Cells in Cardiovascular Surgery Patients
Medium
Report
Cerus Corporation Announces Positive Topline Results for the Phase 3 Clinical Trial of the INTERCEPT Blood System for Red Blood Cells in Cardiovascular Surgery Patients
3/8
06:39 am
cers
Earnings Release: Here's Why Analysts Cut Their Cerus Corporation (NASDAQ:CERS) Price Target To US$4.13 [Yahoo! Finance]
Low
Report
Earnings Release: Here's Why Analysts Cut Their Cerus Corporation (NASDAQ:CERS) Price Target To US$4.13 [Yahoo! Finance]
3/7
01:53 pm
cers
Cerus Corp (CERS) Posts Narrowed Q4 Net Loss and Achieves Adjusted EBITDA Breakeven [Yahoo! Finance]
Medium
Report
Cerus Corp (CERS) Posts Narrowed Q4 Net Loss and Achieves Adjusted EBITDA Breakeven [Yahoo! Finance]
3/7
11:50 am
cers
Cerus Corporation (NASDAQ:CERS) Q4 2023 Earnings Call Transcript [Yahoo! Finance]
Low
Report
Cerus Corporation (NASDAQ:CERS) Q4 2023 Earnings Call Transcript [Yahoo! Finance]
3/7
10:59 am
cers
Cerus Co. (NASDAQ: CERS) had its "equal weight" rating re-affirmed by analysts at Stephens. They now have a $2.50 price target on the stock.
Medium
Report
Cerus Co. (NASDAQ: CERS) had its "equal weight" rating re-affirmed by analysts at Stephens. They now have a $2.50 price target on the stock.
3/7
06:23 am
cers
Cerus Full Year 2023 Earnings: EPS Beats Expectations, Revenues Lag [Yahoo! Finance]
Low
Report
Cerus Full Year 2023 Earnings: EPS Beats Expectations, Revenues Lag [Yahoo! Finance]
3/6
12:35 pm
cers
Cerus Co. (NASDAQ: CERS) had its "overweight" rating re-affirmed by analysts at Cantor Fitzgerald. They now have a $3.00 price target on the stock.
Low
Report
Cerus Co. (NASDAQ: CERS) had its "overweight" rating re-affirmed by analysts at Cantor Fitzgerald. They now have a $3.00 price target on the stock.
3/5
04:10 pm
cers
Cerus Corporation Announces Fourth Quarter and Full-Year 2023 Financial Results [Yahoo! Finance]
High
Report
Cerus Corporation Announces Fourth Quarter and Full-Year 2023 Financial Results [Yahoo! Finance]
3/5
04:00 pm
cers
Cerus Corporation Announces Fourth Quarter and Full-Year 2023 Financial Results
High
Report
Cerus Corporation Announces Fourth Quarter and Full-Year 2023 Financial Results
2/26
09:32 am
cers
Microsize Announces Expanded CDMO Relationship with Cerus Corporation [Yahoo! Finance]
Low
Report
Microsize Announces Expanded CDMO Relationship with Cerus Corporation [Yahoo! Finance]
2/20
08:30 am
cers
Cerus Corporation to Release Fourth Quarter and Full-Year 2023 Financial Results on March 5, 2024
Low
Report
Cerus Corporation to Release Fourth Quarter and Full-Year 2023 Financial Results on March 5, 2024
2/1
08:30 am
cers
Cerus Corporation to Participate in Upcoming Investor Conferences
Medium
Report
Cerus Corporation to Participate in Upcoming Investor Conferences